Advertisement
News
Subscribe to MDT Magazine News

IBM Expands the Institute for Electronic Government in Washington to Focus on Advancements in Analytics and Cloud Computing

March 1, 2011 6:38 am | by IBM | Comments

IBM today announced a major expansion of its Institute for Electronic Government (IEG) in Washington, D.C., adding cloud computing and analytics capabilities for public sector organizations around the world. E-mail this page Save to del.icio.us Digg this

CIM Centers at PLTW High Schools Add VEX Robotics Design System with $400,000 in SME-EF Funding

March 1, 2011 6:38 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 28, 2011 — Workers who have transferable skills of advanced manufacturing technology are golden for industries with little time to waste and anxious to expand their restructured companies. More

Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split

March 1, 2011 6:35 am | by Bio-Medicine.Org | Comments

RICHMOND, Va., March 1, 2011 /- Insmed Incorporated (Nasdaq: INSM ), a biopharmaceutical company, announced today that Insmed's shareholders approved the proposal relating to the conversion of Insmed's Series B Conditional Convertible Preferred Stock (Series B Preferred Stock) into...

TOPICS:
Advertisement

FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease

March 1, 2011 6:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD). (Logo:...

TOPICS:

Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter

March 1, 2011 6:34 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., March 1, 2011 /- Perrigo (Nasdaq: PRGO;TASE) today announced that, as part of the anticipated follow-up to the warning letter Perrigo received on April 30, 2010, the Detroit Office of the Food and Drug Administration (FDA) has arrived at their Allegan facility for the...

TOPICS:

RXi raising $8.1M from public equities sale

March 1, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

RXi Pharmaceuticals Corp. of Worcester is raising $8.1 million through a public stock offering of 6 million units of combined stocks and warrants, with proceeds to be used for "general corporate purposes."

Quiet NeuroPhage nabs $12.4M in Series B round

March 1, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based NeuroPhage Pharmaceuticals Inc. has landed $12.4 million in a Series B round of funding led by MerieuxDeveloppement, the investment arm of French industrial holding company InstitutMerieux.

Volcano Corporation Announces Webcast of March 9th Analyst Day

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 1, 2011 /-Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, will hold its 2011 Analyst Day on Wednesday,...

TOPICS:
Advertisement

Former PayPal, Palantir Executive Jason Portnoy Joins Practice Fusion as CFO

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, March 1, 2011 /- Practice Fusion, the fastest growing Electronic Medical Record (EMR) community in the US, today announced Jason Portnoy as the company's Chief Financial Officer.  Practice Fusion delivers the leading, free, cloud-based EMR to physicians; enabling...

TOPICS:

BioMarin to Present at the Cowen Health Care Conference

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

NOVATO, Calif., March 1, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Cowen Health Care Conference in Boston on Tuesday, March 8, 2011 at 8:00 a.m. ET....

TOPICS:

Veteran Executive Ron Wall Joins Advanstar Communications as Executive Vice President, Pharmaceutical/Science

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SANTA MONICA, Calif., March 1, 2011 /- Advanstar Communications, Inc., a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries, announced today that it has appointed Ron Wall to fill its newly created position of...

TOPICS:

Merger of Four Pharmaceutical Companies Announced

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

COOKEVILLE, Tenn., March 1, 2011 /- Four successful contract packaging and re-packaging companies in the pharmaceutical industry recently joined forces to create a new, single-source industry leader called Aphena Pharma Solutions . Aphena is a new corporation based on a strategic alliance...

TOPICS:

Chimerix to Present at Cowen and Company 31st Annual Health Care Conference

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

DURHAM, N.C., March 1, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics to address life-threatening diseases, announced today that Kenneth I. Moch, President and Chief Executive Officer, will present at the Cowen and Company 31st Annual...

TOPICS:

Prometheus Highlights Record Performance in 2010

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 1, 2011 /- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today highlighted its financial results and product development progress for the year ended December 31, 2010. "Prometheus had another record year in 2010, our 14th consecutive...

TOPICS:

Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, March 1, 2011 /- Nektar Therapeutics' (Nasdaq: NKTR ) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the 31st Annual Cowen and Company Healthcare Conference at the Boston Marriott Copley Place on Tuesday, March 8, 2011 at 11:00 a.m....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading